{
  "main_header": {
    "sid": 970356,
    "name": "Pfizer",
    "stock_name": "Pfizer",
    "full_name": "Pfizer Ltd.",
    "name_url": "stocks-analysis/pfizer",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,859.30",
    "chg": 7.4,
    "chgp": "0.15%",
    "dir": 1,
    "prev_price": "4,851.90",
    "mcapval": "21,950.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500680,
    "symbol": "PFIZER",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE182A01018",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "29.55 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/pfizer-970356-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "970356",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/pfizer-970356"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Mar-2026",
      "details": "Intimation regarding change in Senior Management Personnel of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Mar-2026",
      "details": "The trading window for trading in shares of the Company shall remain closed from Tuesday March 31 2026 (close of business) till 48 hours after financial results are made public.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "09-Feb-2026",
      "details": "Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025 which were approved by the Board of Directors of the Company at their Meeting held today i.e. February 9 2026 that commenced at 3.00 p.m. and concluded at 4.45 p.m.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Pfizer Ltd. has declared <strong>350%</strong> dividend, ex-date: 09 Jul 25",
          "dt": "2025-07-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News